Quality of life in Wilson's disease

R. Komal Kumar, A. Taly*, K. P S Nair, S. Sinha, L. Prashanth, N. Vidya, G. Arunodaya, S. Rao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson's disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p <0.01). The NSS correlated inversely with the physical domain ( p <0.02), while the duration of treatment had a positive correlation with the physical domain ( p <0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.

Original languageEnglish
Pages (from-to)37-43
Number of pages7
JournalAnnals of Indian Academy of Neurology
Volume11
Issue number1
Publication statusPublished - Jan 1 2008

Keywords

  • Quality of life
  • WHO-BREF
  • Wilson's disease

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Quality of life in Wilson's disease'. Together they form a unique fingerprint.

Cite this